TORONTO, Canada, October 16, 2009 -- Biovail Corporation (NYSE, TSX: BVF) today announced that the Company has received the 2009 Company of the Year Award from the Life Science Association of Manitoba (LSAM). The Award was presented earlier this week at LSAM’s Life Science Awards Dinner in Winnipeg, Manitoba.
In accepting the award, Tony Martinez, Vice-President and General Manager of Biovail’s Steinbach, Manitoba facility said, “Having been a proud member of the Manitoba business community since 1995, we are delighted to receive this honor, which reflects the dedication and professionalism of all of our employees in Manitoba as well as our valued business partners. Manitoba has provided a deep pool of resources that have helped Biovail become a leading pharmaceutical manufacturer.”
Mr. Martinez added, “Biovail’s Steinbach operations are an important component of the Company’s business strategy of developing and commercializing pharmaceuticals that target unmet medical needs in specialty central nervous system disorders.”
About LSAM
The Life Science Association of Manitoba represents the provinces biotech, pharmaceutical, medical device and health products industries. The LSAM builds and supports the industries through: Sector Promotion, Training and Advocacy. The Association’s annual awards recognize leaders and innovators of the life science community.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company’s Web site at
www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [email protected].
